The effect of chelation on blood pressure in lead-exposed children: A randomized study

Environmental Health Perspectives

Volumn 114, Issue 4, 2006, Pages 579-583

  Chen, Aimin ^a   Rhoads, George G ^b   Cai, Bo ^a   Salganik, Mikhail ^c   Rogan, Walter J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood pressure; Chelation; Child; Lead; Succimer

Indexed keywords

LEAD; PLACEBO; SUCCIMER;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CHELATION THERAPY; CHILDHOOD DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; PARAMETRIC TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; HUMANS; LEAD; PLACEBOS;

EID: 33645639946     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8634     Document Type: Article

References (39)

1. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Auto Control 19(6):716-723.
2. ATSDR. 1999. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
3. Chai SS, Webb RC. 1988. Effects of lead on vascular reactivity. Environ Health Perspect 78:85-89.
4. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. 2001. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol 153:164-171.
5. de Kort WL, Verschoor MA, Wibowo AA, van Hemmen JJ. 1987. Occupational exposure to lead and blood pressure: a study in 105 workers. Am J Ind Med 11:145-156.
6. Den Hond E, Nawrot T, Staessen JA. 2002. The relationship between blood pressure and blood lead in NHANES III. National Health and Nutritional Examination Survey. J Hum Hypertens 16:563-568.
7. Den Hond E, Nawrot T, Staessen JA. 2003. Hypertension and low-level lead exposure: a scientific issue or a matter of faith? [Letter]. Hypertension 42:e9. doi:10.1161/01.HYP.0000085859.22259.42 [Online 28 July 2003].
8. Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, et al. 2004. Effect of chelation therapy on the neuropsychological and behavioral development of leadexposed children after school entry. Pediatrics 114:19-26.
9. Ding Y, Vaziri ND, Gonick HC. 1998. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 76:107-113.
10. Factor-Litvak P, Kline JK, Popovac D, Hadzialjevic S, Lekic V, Preteni-Rexhepi E, et al. 1996. Blood lead and blood pressure in young children. Epidemiology 7:633-637.
11. Fewtrell LJ, Pruss-Ustun A, Landrigan P, Ayuso-Mateos JL. 2004. Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res 94:120-133.
12. Friedlander MA, Brooks CT, Sheehe PR. 1981. Blood pressure and creatinine clearance in lead-exposed children: the effect of treatment. Arch Environ Health 36:310-315.
13. Gillman MW, Cook NR. 1995. Blood pressure measurement in childhood epidemiological studies. Circulation 92:1049-1057.
14. Gillman MW, Hood MY, Moore LL, Nguyen US, Singer MR, Andon MB. 1995. Effect of calcium supplementation on blood pressure in children. J Pediatr 127:186-192.
15. Gillman MW, Oliveria SA, Moore LL, Ellison RC. 1992. Inverse association of dietary calcium with systolic blood pressure in young children. JAMA 267:2340-2343.
16. Graziano JH, Lolacono NJ, Meyer P. 1988. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr 113:751-757.
17. Hertz-Picciotto I, Croft J. 1993. Review of the relation between blood lead and blood pressure. Epidemiol Rev 15:352-373.
18. Hu H. 1991. A 50-year follow-up of childhood plumbism. Hypertension, renal function, and hemoglobin levels among survivors. Am J Dis Child 145:681-687.
19. Jhaveri RC, Lavorgna L, Dube SK, Glass L, Khan F, Evans HE. 1979. Relationship of blood pressure to blood lead concentrations in small children. Pediatrics 63:674-676.
20. Miller DT, Paschal DC, Gunter EW, Stroud PE, D'Angelo J. 1987. Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier. Analyst 112:1701-1704.
21. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, et al. 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289:1523-1532.
22. National High Blood Pressure Education Program. 2004. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576.
23. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. 2002. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 16:123-131.
24. Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. 1998. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect 106:745-750.
25. Preuss HG, Jiang G, Jones JW, Macarthy PO, Andrews PM, Gondal JA. 1994. Early lead challenge and subsequent hypertension in Sprague-Dawley rats. J Am Coll Nutr 13:578-583.
26. Development Core Team. 2004. R: A Language and Environment for Statistical Computing. Vienna:R Foundation for Statistical Computing.
27. Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, et al. 2001. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med 344:1421-1426.
28. Rogan WJ, Hogan MD, Chi PY, Cowan D. 1978. Blood pressure and lead levels in children. J Environ Pathol Toxicol 2:517-519.
29. Rothenberg SJ, Kondrashov V, Manalo M, Jiang J, Cuellar R, Garcia M, et al. 2002. Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol 156:1079-1087.
30. Selbst SM, Sokas RK, Henretig FM, Weller SC, Tershakovec AM. 1993. The effect of blood lead on blood pressure in children. J Environ Pathol Toxicol Oncol 12:213-218.
31. Sharp DS, Becker CE, Smith AH. 1987. Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol 2:210-232.
32. Sinaiko AR. 1996. Hypertension in children. N Engl J Med 335:1968-1973.
33. Staessen JA, Lauwerys RR, Bulpitt CJ, Fagard R, Lijnen P, Roels H, et al. 1994. Is a positive association between lead exposure and blood pressure supported by animal experiments? Curr Opin Nephrol Hypertens 3:257-263.
34. Telisman S, Pizent A, Jurasovic J, Cvitkovic P. 2004. Lead effect on blood pressure in moderately lead-exposed male workers. Am J Ind Med 45:446-454.
35. TLC Trial. 1998. The Treatment of Lead-Exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers. Paediatr Perinat Epidemiol 12:313-333.
36. Victery W. 1988. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ Health Perspect 78:71-76.
37. Victery W, Vander AJ, Markel H, Katzman L, Shulak JM, Germain C. 1982a. Lead exposure, begun in utero, decreases renin and angiotensin II in adult rats. Proc Soc Exp Biol Med 170:63-67.
38. Victery W, Vander AJ, Shulak JM, Schoeps P, Julius S. 1982b. Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med 99:354-362.
39. Vupputuri S, He J, Muntner P, Bazzano LA, Whelton PK, Batuman V. 2003. Blood lead level is associated with elevated blood pressure in blacks. Hypertension 41:463-468.